Ciszewski, Lech,De La Cruz, Marilyn,Karpinski, Piotr H.,Mutz, Michael,Riegert, Christian,Vogel, Caspar,Schneeberger, Ricardo
申请号：
AU2009335924
公开号：
AU2009335924B2
申请日:
2009.12.16
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
This invention relates to a hemifumarate salt of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid (Compound I), to pharmaceutical compositions comprising this salt, to processes for forming this salt and to its use in medical treatment. In addition, the present invention also relates to new polymorphic forms of the hemifumarate salt form of Compound I, as well as to pharmaceutical compositions comprising these polymorphic forms, to processes for obtaining them, and their use in medical treatment.
